Endocrine Cancer
Conference Coverage
Contralateral nodal thyroid metastases show slow progression
BOSTON – In some thyroid cancers, a small level III contralateral nodal metastasis may be watched safely rather than resected.
Conference Coverage
Revised thyroid Bethesda System resets malignant risks
BOSTON – Revised thyroid cancer cytology system “limits malignancy to cases with features of classic malignant papillary thyroid carcinoma.”
Conference Coverage
VIDEO: Lenvatinib’s real-world thyroid cancer performance matches trial
The median time of progression-free survival was 10 months in the registry and 18 months in the pivotal trial.
Conference Coverage
VIDEO: Less follow-up proposed for low-risk thyroid cancer
BOSTON – Can some patients with good treatment responses safely transition to follow-up monitoring at longer intervals?
From the Journals
USPSTF: No thyroid cancer screening for asymptomatic adults
The harms of screening asymptomatic adults for thyroid cancer outweigh the benefits, according to the U.S. Preventive Services Task Force.
From the Journals
Metformin linked with better survival in RCC patients with diabetes
A meta-analysis of eight studies including 254,329 patients found better survival with metformin use.
Conference Coverage
Temozolomide may help half of patients with aggressive pituitary tumors
Temozolomide, an alkylating agent approved for glioblastoma, improved long-term survival in about half of patients who took it for aggressive...
Conference Coverage
Thyroid cancer incidence: It’s not all good news
Despite a general upward trend over the past 3 decades, the incidence of thyroid cancer has dropped since 2010 in certain populations.
Conference Coverage
Peptide vaccine shows early promise in ovarian, endometrial cancers
E39+GM-CSF was well tolerated and exhibited a statistically significant, dose-dependent effect on recurrence and disease-free survival.
From the Journals
Standardize opioid prescribing after endocrine neck surgery, researchers say
Twenty oral morphine equivalents is the ideal amount of pain relief medication with which to discharge outpatients after thyroidectomy or...
Conference Coverage
Cabozantinib shows promise for carcinoid tumors, pNET
Cabozantinib treatment was associated with objective tumor responses and encouraging progression-free survival in advanced carcinoid and...